New Delhi: AAP MLA Atishi Tuesday said Delhi is left with only three days' stock of Covishield vaccine for the 18-44 age group, and if more doses are not supplied the vaccination drive for this category will have to be stopped in the city.
Delhi's stock of Covaxin — the second Coronavirus vaccine in use in the country — for this age group has already ended, leading the AAP government to shut vaccination centres administering Bharat Biotech-made jabs to this category of beneficiaries.
Releasing the city's latest "vaccination bulletin", Atishi said the city will have only three days of Covishield stock left for the 18-44 age group after Tuesday evening.
Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.
Stay updated with all the Delhi Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.